We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods

    Background

    Most studies examining the simultaneous use of cannabis with other drugs have focused on cannabis and alcohol, with fewer studies examining...

    Cianna J. Piercey, Eleftherios Hetelekides, Hollis C. Karoly in Journal of Cannabis Research
    Article Open access 11 July 2024
  2. Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022

    Introduction

    In recent years, pregabalin has received growing attention due to its abuse liability. The aim of this study was to further characterize...

    Clément Garnier, Martin Schein, ... Joëlle Micallef in CNS Drugs
    Article 11 July 2024
  3. The influence of PER3 VNTR genotypes on the age of onset in a group of bipolar I disorder patients: an exploratory study

    Background

    PER3 is a circadian gene that contains a variable number of tandem repeats (VNTR) which codifies for three genotypes: 4/4; 4/5; and 5/5...

    Tommaso Barlattani, Bettina Soltmann, ... Philipp Ritter in International Journal of Bipolar Disorders
    Article Open access 11 July 2024
  4. Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial

    Background

    Cigarette smoking remains a leading cause of preventable illness and death, underscoring the need for effective evidence-based smoking...

    Helen Schiek, Tobias Esch, ... Cosima Hoetger in Addiction Science & Clinical Practice
    Article Open access 10 July 2024
  5. Versorgung von Traumafolgestörungen

    Ingo Schäfer, Ulrich Voderholzer in Der Nervenarzt
    Article 03 July 2024
  6. Eine neue Ära für Der Nervenarzt

    Frank Schneider, Andreas Meyer-Lindenberg, Paul Herrmann in Der Nervenarzt
    Article 03 July 2024
  7. Understanding the epidemiology and perceived efficacy of cannabis use in patients with chronic musculoskeletal pain

    Background

    The belief that cannabis has analgesic and anti-inflammatory properties continues to attract patients with chronic musculoskeletal (MSK)...

    Timothy Leroux, Prabjit Ajrawat, ... Hance Clarke in Journal of Cannabis Research
    Article Open access 03 July 2024
  8. A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial

    Background

    TV-46000 is a long-acting subcutaneous antipsychotic (LASCA) formulation of risperidone that is approved by the United States Food and Drug...

    John M. Kane, Roy Eshet, ... Christoph U. Correll in CNS Drugs
    Article Open access 02 July 2024
  9. (Auto‑)Immunität bei fokaler Epilepsie: Mechanismen (auto‑)immun-inflammatorischer epileptogener Neurodegeneration

    Objective

    While the neuronal mechanisms of epileptic hyperexcitability (HE) have been studied in detail, recent findings suggest that extraneuronal,...

    Nico Melzer, Katharina Weber, ... Felix Rosenow in Der Nervenarzt
    Article Open access 02 July 2024
  10. Immunologische Grundlagen neurologischer Erkrankungen

    Background

    Neurodegenerative diseases represent an increasing challenge in ageing societies, as only limited treatment options are currently available.

    ...
    Hansjörg Schild, Tobias Bopp in Der Nervenarzt
    Article 02 July 2024
  11. The State of Synthetic Cannabinoid Medications for the Treatment of Pain

    Synthetic cannabinoids are compounds made in the laboratory to structurally and functionally mimic phytocannabinoids from the Cannabis sativa L . ...

    Anca Maglaviceanu, Miki Peer, ... Hance Clarke in CNS Drugs
    Article 01 July 2024
  12. Psychotherapeutenausbildung an den Kliniken für Psychiatrie und Psychotherapie

    Andreas Schuld, Thomas Pollmächer, ... Sylvia Claus in Der Nervenarzt
    Article 01 July 2024
  13. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis

    Clozapine-induced myocarditis (CIM) is among the most important adverse events limiting the use of clozapine as the most effective treatment for...

    Mishal Qubad, Gabriele Dupont, ... Robert A. Bittner in CNS Drugs
    Article Open access 01 July 2024
  14. Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development

    Alzheimer’s disease (AD) is a complex multifaceted disease. Recently approved anti-amyloid monoclonal antibodies slow disease progression by...

    Jeffrey L. Cummings, Amanda M. Leisgang Osse, ... **gchun Chen in CNS Drugs
    Article Open access 27 June 2024
  15. Towards a Prescription for Change: Interprofessional Management of Polypharmacy and Deprescribing

    Purpose of Review

    Deprescribing, systematically discontinuing unnecessary or harmful medications, gains importance in healthcare. With rising...

    Aimee Elizabeth Perron in Current Geriatrics Reports
    Article Open access 27 June 2024
  16. Beispiel einer ethischen Fallbesprechung in der Psychiatrie

    Alfred Simon, Katrin Radenbach in Der Nervenarzt
    Article 27 June 2024
Did you find what you were looking for? Share feedback.